Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
Welcome to MIA Reports, showcasing our independent and original journalism devoted to rethinking psychiatry. We take selected MIA Reports and provide them as audio articles. Click here for the text version of this and all of our MIA reports.
The Whistleblower and Penn: A Final Accounting of Study 352
Written by Peter Simons, read by James Moore, first published on Mad in America, December 29, 2019.
Although the general story of ghostwriting in trials of psychiatric drugs is now pretty well known, the details of the corruption in specific trials are still emerging into the public record, often a decade or more after the original sin of fraudulent publication. The latest study to finally see the full light of day is GlaxoSmithKline’s study 352.
Perhaps the most infamous ghostwritten study is GSK’s study 329, which, in a 2001 report published in the American Journal of Psychiatry, falsely touted paroxetine (Paxil) as an effective treatment for adolescent depression. The company paid over $3 billion in penalties for fraud.
That same year, study 352 made its first appearance in the research literature. That was when Charles Nemeroff, who in the years ahead would become the public face of research misconduct, “authored” an article on the efficacy of paroxetine for bipolar disorder. It has taken 18 years for the full story of that corruption to become known, the final chapter recently emerging when a large cache of study 352 documents—emails, memos, and other internal correspondence between the key players—was made public.
The documents reveal a web of corruption that went beyond the fraud of ghostwriting into the spinning of negative results into positive conclusions, and the abetting of that corruption by an editor of the scientific journal that published the article. The documents also reveal a whitewashing of the corruption by the University of Pennsylvania.
However, it was the publication of these documents that provided Jay Amsterdam, an investigator in the trial who turned whistleblower after he smelled a rat, with a chance to say “case closed.” Amsterdam and Leemon McHenry have now published two articles that provide a step-by-step deconstruction of the study—the ghostwriting, the spinning of results, the betrayal of public trust.
Here is the story of that whistleblowing.
Art and Transformation - Creating Justice in Mental Health Care
David Healy – Polluting Our Internal Environments: The Perils of Polypharmacy
Morgan Shields - Breaking Academia's Silence on Inpatient Psychiatry
Anders Sørensen - Tackling Psychiatric Drug Withdrawal Through Research and in Practice
Justin Karter - Exploring the Fault Lines in Mental Health Discourse
Jim Flannery - Sorry It's Not Funny – Comedy, Hip-Hop and Activism
Diana Rose - Is Service-User Research Possible in Mental Health?
Jon Jureidini – Evidence-Based Medicine in a Post-Truth World
Liam MacGabhann, Martha Griffin, Harry Gijbels and Elaine Browne - The Launch of Mad in Ireland
Beverley Thomson – Antidepressed - Antidepressant Harm and Dependence
John Read and Jeffrey Masson - Biological Psychiatry and the Mass Murder of “Schizophrenics”
Kaori Wada - How Grief Became a Disorder and What This Means About Us
Andrew Scull - Desperate Remedies: Psychiatry’s Turbulent Quest to Cure Mental Illness
Kristina Marusic - Pollution's Mental Toll
Jessica Taylor - Pathologized Since Eve - Women, Trauma, and Sexy but Psycho
Jock McLaren – The Biopsychosocial Model is a Mirage, Time for a Biocognitive Model?
Tara Thiagarajan - Mental Wellbeing Among Internet-enabled Populations of the World
Bruce Cohen - The Failings of “Mental Health”: How a Seemingly Benign Concept Might be Dangerous
Jennifer Barkin - New Tools to Support New Moms
Alice and Kenneth Thompson - Bringing Integrative Community Therapy to Pittsburgh
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast